Downloading...
Download

Thyrocarelong

Thyrocare is carefully consolidating and might take off. Thyrocare Technologies Ltd. is the 1st fully advanced and automated laboratory with a strong presence in over 2000 cities both nationally and internationally. The company conduct esoteric test with its Central Processing Laboratory (CPL) and also have Regional Processing Laboratories (RPLs) in major metro cities in India and parts of Asia. Thyrocare Technologies CMP is 569.50. The Negative aspects of the company are high valuation (P.E. = 50.2), declining annual net profits, FIIs are decreasing and high promoter pledge. The Positive aspects of the company are improving cash from operations annual and MFs are increasing stake. Entry after closing above 580. Target in the stock will be 630. Long term target in the stock will be 674. Stop loss in the stock should be maintained at closing below 516. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:THYROCARELong
by Happy_Candles_Investment